Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2022 Earnings Conference Call March 31, 2023 9:00 AM ET

Company Participants

Scott Gordon - CORE, Investor Relations

Rick Eiswirth - President & CEO

Russell Skibsted - SVP and CFO

Conference Call Participants

Alex Nowak - Craig-Hallum Capital Group

Yi Chen - H.C. Wainwright & Co., LLC

Operator

Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately 1 hour after the end of the call through July 1, 2023.

I would now like to turn the call over to Scott Gordon of CORE IR, the Company's Investor Relations Firm. Please go ahead, sir.

Scott Gordon

Thank you, Jason, and good morning, everyone and thank you for participating in today's conference call. Joining me from Alimera's leadership team are Rick Eiswirth, President and Chief Executive Officer; and Russell Skibsted, Chief Financial Officer.

During this call, management will be making forward-looking statements, including statements that address Alimera's expectations for future performance or operational results. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements.

For more information about these risks, please refer to the risk factors described in Alimera's most recently filed periodic reports on Form 10-K and Form 10-Q, including the Form 10-K and Form 8-K filed with the SEC today and Alimera's press release that accompanies this call, particularly the cautionary statements in it.

Today's conference call includes adjusted EBITDA and adjusted net product revenue, non-GAAP financial measures that Alimera believes can be useful in evaluating its performance. We should not consider this additional information in isolation or as a substitute for results prepared in accordance with GAAP. For reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures, please see the reconciliation tables located in Alimera's earnings press release.

The content of this call contains time-sensitive information that is accurate only as of today, March 31, 2023. Except as required by law, Alimera disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call.